Cannabidiol 133mg + Cannabigerol 66mg + Tetrahydrocannabinol 4mg Vs Placebo As Adjuvant Treatment in Chronic Migraine -

Clinical trial NCT04989413 · TERMINATED

Trial details

NCT number: NCT04989413
Sponsor: Hospital Israelita Albert Einstein
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Chronic Migraine, Headache Overuse Headache Medication

Start date: 2022-10-18
Primary completion: 2025-02-20
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.